James Hardie ASX shares climb as Jefferies backs pricing muscle
BUZZ-James Hardie ASX shares climb as Jefferies backs pricing muscle ** James Hardie's JHX.AX ASX-listed shares rally as much as 3.4% to A$37.085, their sharpest intraday pct rise since August 7
** Jefferies ("buy", $25.53 PT) notes that the fibre cement maker's pricing power, resilient siding demand and material conversion tailwinds
** Says JHX to get "good traction" as it is set to lift prices 5% across key products from January, targeting nearly 3.5%-4% annual pricing growth despite housing softness
** Stronger siding demand, higher oriented strand board prices and savings from idling Jasper mill should help offset inflation in late 2026 - Jefferies
** ASX-listed shares rated "buy" on average by 6 analysts, mean PT A$44.84 - LSEG-compiled data
** US-listed shares JHX.N rated "strong buy" on average by 7 analysts, mean PT $36.14 - LSEG-compiled data
** YTD ASX-listed stock up about 19% vs 23% rise in US
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))
Recent news on James Hardie Industries
See all newsJames Hardie ASX shares climb as Jefferies backs pricing muscle
James Hardie to sell Fermacell for $981 million, looks to exit Europe (updated)
James Hardie to sell European operations to Holcim for $981 million
Brief: Holcim To Acquire Fermacell
James Hardie faces another class action over disclosures, earnings forecasts (updated)